The price of Chimerix Inc. (NASDAQ: CMRX) closed at $1.82 in the last session, down -0.55% from day before closing price of $1.83. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 500655 shares were traded. CMRX stock price reached its highest trading level at $1.8450 during the session, while it also had its lowest trading level at $1.7900.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
We take a closer look at CMRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.40 and its Current Ratio is at 16.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, CapitalOne on September 07, 2022, initiated with a Overweight rating and assigned the stock a target price of $7.
On April 29, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $20.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 26 when Jakeman David sold 3,230 shares for $1.76 per share. The transaction valued at 5,686 led to the insider holds 136,752 shares of the business.
MIDDLETON FRED A bought 20,000 shares of CMRX for $37,176 on Sep 29. The Director now owns 40,000 shares after completing the transaction at $1.86 per share. On Sep 29, another insider, Jakeman David, who serves as the Principal Accounting Officer of the company, sold 4,400 shares for $1.86 each. As a result, the insider received 8,185 and left with 127,532 shares of the company.
As of this moment, Chimerix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.89 while its Price-to-Book (P/B) ratio in mrq is 0.58.
Stock Price History:
Over the past 52 weeks, CMRX has reached a high of $6.43, while it has fallen to a 52-week low of $1.27. The 50-Day Moving Average of the stock is 1.9534, while the 200-Day Moving Average is calculated to be 2.2352.
According to the various share statistics, CMRX traded on average about 917.70K shares per day over the past 3-months and 642.66k shares per day over the past 10 days. A total of 87.64M shares are outstanding, with a floating share count of 79.26M. Insiders hold about 0.80% of the company’s shares, while institutions hold 62.30% stake in the company. Shares short for CMRX as of Oct 13, 2022 were 3.57M with a Short Ratio of 2.65M, compared to 3.33M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.08% and a Short% of Float of 4.27%.
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of $2.14 for the current quarter, with a high estimate of $2.84 and a low estimate of -$0.26, while EPS last year was -$0.21. The consensus estimate for the next quarter is $0.21, with high estimates of $2.44 and low estimates of -$0.26.
Analysts are recommending an EPS of between $2.06 and $1.57 for the fiscal current year, implying an average EPS of $1.86. EPS for the following year is -$0.98, with 6 analysts recommending between -$0.9 and -$1.09.
According to 6 analysts, the current quarter’s revenue is expected to be $219.37M. It ranges from a high estimate of $272.6M to a low estimate of $32M. As of the current estimate, Chimerix Inc.’s year-ago sales were $5.98M, an estimated increase of 3,568.40% from the year-ago figure.
A total of 6 analysts have provided revenue estimates for CMRX’s current fiscal year. The highest revenue estimate was $273.06M, while the lowest revenue estimate was $225.5M, resulting in an average revenue estimate of $259.94M. In the same quarter a year ago, actual revenue was $1.98M, up 13,034.90% from the average estimate.